These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33464375)

  • 1. [Perioperative cardioprotection - From bench to bedside : Current experimental evidence and possible reasons for the limited translation into the clinical setting].
    Torregroza C; Roth S; Feige K; Lurati Buse G; Hollmann MW; Huhn R
    Anaesthesist; 2021 May; 70(5):401-412. PubMed ID: 33464375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative Cardioprotection: Clinical Implications.
    Roth S; Torregroza C; Huhn R; Hollmann MW; Preckel B
    Anesth Analg; 2020 Dec; 131(6):1751-1764. PubMed ID: 33186162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
    Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
    Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives.
    Duicu OM; Angoulvant D; Muntean DM
    Can J Physiol Pharmacol; 2013 Aug; 91(8):657-62. PubMed ID: 23889135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative Cardioprotection: General Mechanisms and Pharmacological Approaches.
    Torregroza C; Raupach A; Feige K; Weber NC; Hollmann MW; Huhn R
    Anesth Analg; 2020 Dec; 131(6):1765-1780. PubMed ID: 33186163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
    Sanada S; Komuro I; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications.
    Roth S; Torregroza C; Feige K; Preckel B; Hollmann MW; Weber NC; Huhn R
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection with volatile anesthetics in cardiac surgery.
    Lorsomradee S; Cromheecke S; Lorsomradee S; De Hert SG
    Asian Cardiovasc Thorac Ann; 2008 Jun; 16(3):256-64. PubMed ID: 18515682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Future of Cardioprotection-Pointing Toward Patients at Elevated Risk as the Target Populations.
    Bøtker HE
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):487-493. PubMed ID: 32597205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.
    Hausenloy DJ; Baxter G; Bell R; Bøtker HE; Davidson SM; Downey J; Heusch G; Kitakaze M; Lecour S; Mentzer R; Mocanu MM; Ovize M; Schulz R; Shannon R; Walker M; Walkinshaw G; Yellon DM
    Basic Res Cardiol; 2010 Nov; 105(6):677-86. PubMed ID: 20865418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative Cardioprotection by Remote Ischemic Conditioning.
    Cho YJ; Kim WH
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection by ischemic postconditioning during surgical procedures.
    Sadat U; Walsh SR; Varty K
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):999-1006. PubMed ID: 18666850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
    Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.